Stra13 regulates oxidative stress mediated skeletal muscle degeneration

Human Molecular Genetics

Volumn 18, Issue 22, 2009, Pages 4304-4316

  Vercherat, Cécile ^a   Chung, Teng Kai ^a,b   Yalcin, Safak ^a   Gulbagci, Neriman ^a   Gopinadhan, Suma ^b   Ghaffari, Saghi ^a   Taneja, Reshma ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DYSTROPHIN; HEME OXYGENASE 1; MUTANT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR STRA13; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE OVEREXPRESSION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; STRUCTURE ANALYSIS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; NECROSIS; OXIDATIVE STRESS;

MUS;

EID: 70350688109     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp383     Document Type: Article

References (48)

1. Davies, K.E. and Nowak, K.J. (2006) Molecular mechanisms of muscular dystrophies: Old and new players. Nat. Rev. Mol. Cell. Biol., 7 762-773.
2. Hoffman, E.P., Brown, R.H. Jr. and Kunkel, L.M. (1987) Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
3. Bulfield, G., Siller, W.G., Wight, P.A. and Moore, K.J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA, 81, 1189-1192.
4. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
5. Ervasti, J.M. and Campbell, K.P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell, 66, 1121-1131.
6. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
7. Rowland, L.P. (1980) Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve., 3, 3-20.
8. Vrbova, G. (1983) Duchenne dystrophy viewed as a disturbance of nerve-muscle interactions. Muscle Nerve., 6, 671-675.
9. Turner, P.R., Westwood, T., Regen, C.M. and Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 335, 735-738.
10. Murphy, M.E. and Kehrer, J.P. (1989) Oxidative stress and muscular dystrophy. Chem. Biol. Interact., 69, 101-173.
11. Petrof, B.J. (2002) Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am. J. Phys. Med. Rehabil., 81, S162-S174.
12. Rando, T.A. (2002) Oxidative stress and the pathogenesis of muscular dystrophies. Am. J. Phys. Med. Rehabil., 81, S175-S186.
13. Tidball, J.G. and Wehling-Henricks, M. (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol., 102, 1677-1686.
14. Binder, H.J., Herting, D.C., Hurst, V., Finch, S.C. and Spiro, H.M. (1965) Tocopherol deficiency in man. N. Engl. J. Med., 273, 1289-1297.
15. Pillai, S.R., Traber, M.G., Kayden, H.J., Cox, N.R., Toivio-Kinnucan, M., Wright, J.C., Braund, K.G., Whitley, R.D., Gilger, B.C. and Steiss, J.E. (1994) Concomitant brainstem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J. Neurol. Sci., 123, 64-73.
16. Disatnik, M.H., Dhawan, J., Yu, Y., Flint, M.F., Whirl, M.M., Franco, A.A. and Rando, T.A. (1998) Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state. J. Neurol. Sci., 161, 77-84.
17. Rando, T.A., Disatnik, M.H., Yu, Y. and Franco, A. (1998) Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul. Disord., 8, 14-21.
18. Sun, H., Ghaffari, S. and Taneja, R. (2007) bHLH-Orange transcription factors in development and cancer. Trans. Oncogenomics, 2, 105-118.
19. Sun, H. and Taneja, R. (2000) Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc. Natl. Acad. Sci. USA, 97, 4058-4063.
20. Seimiya, M., Wada, A., Kawamura, K., Sakamoto, A., Ohkubo, Y., Okada, S., Hatano, M., Tokuhisa, T., Watanabe, T., Saisho, H. et al. (2004) Impaired lymphocyte development and function in Clast5/Stra13/ DEC1-transgenic mice. Eur. J. Immunol., 34, 1322-1332.
21. Boudjelal, M., Taneja, R., Matsubara, S., Bouillet, P., Dolle, P. and Chambon, P. (1997) Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev., 11, 2052-2065.
22. Shen, M., Yoshida, E., Yan, W., Kawamoto, T., Suardita, K., Koyano, Y., Fujimoto, K., Noshiro, M. and Kato, Y. (2002) Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J. Biol. Chem., 277, 50112-50120.
23. Sun, H., Lu, B., Li, R.Q., Flavell, R.A. and Taneja, R. (2001) Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol., 2, 1040-1047.
24. Li, Y., Zhang, H., Xie, M., Hu, M., Ge, S., Yang, D., Wan, Y. and Yan, B. (2002) Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J., 367 413-422.
25. Bek, M.J., Wahle, S., Müller, B., Benzing, T., Huber, T.B., Kretzler, M., Cohen, C., Busse-Grawitz, A. and Pavenstädt, H. (2003 Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes. FASEB J., 17, 682-684.
26. Ivanova, A.V., Ivanov, S.V., Zhang, X., Ivanov, V.N., Timofeeva, O.A. and Lerman, M.I. (2004) STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. J. Mol. Biol., 340 641-653.
27. Thin, T.H., Li, L., Chung, T.K., Sun, H. and Taneja, R. (2007) Stra13 is induced by genotoxic stress and regulates ionizing-radiation-induced apoptosis. EMBO Rep., 8, 401-407.
28. Sun, H., Li, L., Vercherat, C., Gulbagci, N.T., Acharjee, S., Li, J., Chung, T.K., Thin, T.H. and Taneja, R. (2007) Stra13 regulates satellite cell activation by antagonizing Notch signaling. J. Cell. Biol., 177, 647-657.
29. Hamer, P.W., McGeachie, J.M., Davies, M.J. and Grounds, M.D. (2002) Evans Blue as an in vivo marker of myofibre damage: Optimizing parameters for detecting initial myofibre membrane permeability. J. Anat., 200, 69-79.
30. Bodensteiner, J.B. and Engel, A.G. (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567,000 muscle fibers in 114 biopsies. Neurology, 28, 439-446.
31. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell. Biol., 139, 375-385.
32. Webster, C., Silberstein, L., Hays, A.P. and Blau, H.M. (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell, 52, 503-513.
33. Ohlendieck, K. and Campbell, K.P. (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell. Biol., 115, 1685-1694.
34. Mayer, U., Saher, G., Fassler, R., Bornemann, A., Echtermeyer, F., von der Mark, H., Miosge, N., Poschl, E. and von der Mark, K. (1997) Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat. Genet., 3, 318-323.
35. Reid, M.B. and Li, Y.P. (2001) Cytokines and oxidative signalling in skeletal muscle. Acta Physiol. Scand., 171, 225-232.
36. Coletti, D., Moresi, V., Adamo, S., Molinaro, M. and Sassoon, D. (2005) Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis, 43, 120-128.
37. Grounds, M.D. and Torrisi, J. (2004) Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J., 18 676-682.
38. Chang, T.S., Cho, C.S., Park, S., Yu, S., Kang, S.W. and Rhee, S.G. (2004) Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem., 279, 41975-41984.
39. Pelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nicoletti, C., Wannenes, F., Battistini, L., Rosenthal, N., Molinaro, M. et al. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J., 21, 1393-1402.
40. Takahashi, T., Morita, K., Akagi, R. and Sassa, S. (2004) Heme oxygenase-1: A novel therapeutic target in oxidative tissue injuries. Curr. Med. Chem., 11, 1545-1561.
41. Ryter, S.W., Alam, J. and Choi, A.M. (2006) Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol. Rev., 86, 583-650.
42. Rushworth, S.A. and MacEwan, D.J. (2008) HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood, 111, 3793-3801.
43. Terry, C.M., Clikeman, J.A., Hoidal, J.R. and Callahan, K.S. (1999) TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am. J. Physiol., 276, H1493-H1501.
44. Petrache, I., Otterbein, L.E., Alam, J., Wiegand, G.W. and Choi, A.M. (2000) Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung. Cell. Mol. Physiol., 278, L312-L319.
45. Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radicals in Biology and Medicine. Oxford University Press, New York, p. 851.
46. Pervaiz, S., Taneja, R. and Ghaffari, S. (2009) Oxidative stress regulation of stem and progenitor cells. Antioxid. Redox Signal. doi:10.1089/ars.2009.2804.
47. McArdle, A., Edwards, R.H. and Jackson, M.J. (1995) How does dystrophin deficiency lead to muscle degeneration? - evidence from the mdx mouse. Neuromuscul. Disord., 5, 445-456.
48. Yalcin, S., Zhang, X., Luciano, J.P., Mungamuri, S.K., Marinkovic, D., Vercherat, C., Sarkar, A., Grisotto, M., Taneja, R. and Ghaffari, S. (2008) Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J. Biol. Chem., 283, 25692-25705.